I read your writeup in full (the markdown you shared) .

### Is it “worth getting published”?

Yes—*but not in its current form if you’re aiming at a main-track ML venue or a bioinformatics journal.* As written, it’s closest to a strong **research report / workshop paper**: it has a clear question, good experimental hygiene in places (especially the “matched negatives” idea), and an honest negative/limited-positive result (which can be publishable if framed correctly).

For a **full conference/journal** bar, the biggest issue is that the central “success” (extra-gradient on PBMC structured n=30) is **narrow, brittle, and not clearly separated from evaluation artifacts**, while the rest of the story is largely “methods don’t generalize / retraining wins.” That *can* be publishable—*but only if you elevate the contribution from “we tried two methods” to “we provide a robust evaluation and a clear empirical finding about where memorization concentrates and why common unlearning ideas fail for VAEs.”*

Below is a publishability-style review: strengths, major blockers, and specific steps that would most increase acceptance odds.

---

## What’s already strong (and worth keeping)

### 1) Clear problem statement + operational success criterion

You define inputs/outputs of unlearning, then define success as matching a retrain “floor” within a band. That’s clean and easy to evaluate.

### 2) The “structured vs scattered forget set” framing is genuinely interesting

Your most valuable empirical insight is:

* **Membership signal is concentrated in coherent biological subpopulations** (structured forget sets), while
* **random scattered cells are weakly memorized** and therefore “unlearning successes” there can be misleading.

That’s a real contribution because it’s domain-grounded and it warns against overclaiming unlearning progress.

### 3) Matched negatives are the right instinct

Controlling for cell type / biological structure is essential in single-cell MIAs. You recognized a major confound and attempted to address it.

### 4) Cross-dataset check + ablations

Many papers stop at one dataset and one forget size. You did:

* PBMC vs Tabula Muris
* forget size and composition ablations
* hyperparameter sweep (λ) on TM
  This is unusually thorough for a class project-style report.

---

## The main publication blockers

These are the issues that, in review, would most likely trigger “reject” unless addressed.

### A) Your “retrain floor” not being ~0.5 is a red flag you must explain rigorously

You treat “AUC near 0.5” as the gold standard, but your **retrain floor is 0.481** and you use that as the target. On its own, that’s not fatal—but reviewers will ask:

* *Why can an attacker distinguish forget cells from matched negatives even when the model was retrained without them?*
* *Does this mean your evaluation still leaks cell-type/tissue signals rather than membership?*
* *Is the attacker learning a direction that flips under retraining?*

Related: you interpret AUC < 0.5 as “over-unlearning / Streisand,” which might be true—but **AUC is symmetric**: if the attacker consistently predicts the opposite label, AUC < 0.5 can mean “still perfectly distinguishable, just inverted.”
To make “over-unlearning” defensible, you need to report something like:

* **membership advantage**: `Adv = 2 * |AUC - 0.5|`
* or equivalently use `max(AUC, 1-AUC)` as the attack success

Then “AUC = 0.38” becomes “attack success = 0.62,” i.e., *still a leak*, and you can separately argue about *directionality* if needed.

**Why this matters:** Right now, your strongest success claim (extra-grad λ=10 hitting 0.482) sits on top of an evaluation framework that will look shaky to a privacy reviewer unless you harden it.

---

### B) The forget-set construction is not aligned with the real privacy story you tell

You motivate with “patient data” and GDPR-like deletion rights, but your structured forget set is **a cluster/cell type** (megakaryocytes / cardiac muscle), not **a user/donor/patient**. That mismatch will prompt:

* “This is *distributional unlearning* (removing a subpopulation), not *user deletion*.”
* “Does this correspond to any plausible deletion request?”

This doesn’t invalidate the work, but you should either:

1. **Reframe honestly**: “We study *subpopulation* unlearning in scRNA VAEs,” or
2. **Add donor-level experiments**: forget *all cells from a donor* (or mouse) using a multi-donor dataset.

If you want “privacy + right-to-be-forgotten” to land, you need (2).

---

### C) Attack model diversity is too narrow for a paper claiming privacy conclusions

You use one post-hoc MLP attacker with a fairly rich feature set. Good start, but publishable privacy evaluation usually needs **multiple, conceptually distinct attacks**, e.g.:

* simple **loss / ELBO threshold** attack
* likelihood ratio / reconstruction-based attacks
* black-box attacks (query-only) vs white-box (latent stats)
* attacks trained with different capacities / regularization
* maybe a nearest-neighbor attack in latent space, etc.

Right now, a reviewer can say: “Your unlearning ‘works’ only against your chosen attacker features.”

You partially address this with “fresh post-hoc attacker” (good), but it’s still one family.

---

### D) Statistical support is thin at the key decision points

You have some seed analysis, but the headline claims rely on very few trials in places:

* “75% success rate (3 of 4 seeds)” for your best result
* ablations sometimes with 3 seeds
* Tabula Muris results look like single runs per λ (it reads that way)

For publication, you want:

* consistent **N seeds** (often 5–10) for every main table entry, or
* bootstrap CIs on AUC, and
* explicit reporting of variance for the key comparisons.

---

### E) Utility evaluation is currently too coarse / a bit suspicious

Your utility table reports identical reconstruction MSE (0.572) across Base / Extra-grad / Fisher / Retrain. That’s possible if it’s rounded heavily or measured on an easy split—but reviewers will be skeptical because Fisher also destroys latent-classification accuracy.

If Fisher damages the latent geometry badly, utility should show up somewhere besides a single recon MSE. For single-cell VAEs, reviewers expect domain-relevant utility like:

* held-out **NB log-likelihood / ELBO**
* downstream: cell-type classification (you have), clustering metrics, silhouette
* marker gene recovery beyond MSE
* differential expression preservation (common scVI evaluation)
* latent embedding quality (UMAP separability, mixing metrics if batch correction)

Right now, utility feels under-instrumented.

---

### F) “Extra-gradient beats retraining” is not true in your own timings

You report extra-gradient takes **42 min vs retrain 10 min**. That’s an important negative result, but it undermines the core motivation of unlearning (“avoid expensive retraining”) unless you:

* scale to larger models where retraining is worse, or
* show extra-gradient has some other advantage (e.g., fewer epochs, less data access), or
* reframe the contribution as: “Adversarial unlearning is expensive and brittle; retraining remains best.”

That reframe is viable—just be explicit.

---

## What I think your “real contribution” is (and how to frame it)

If you submit this, the most publishable framing is:

> **A careful empirical evaluation of unlearning in single-cell VAEs showing that memorization (and thus the meaningful unlearning problem) concentrates in coherent biological subpopulations; standard unlearning techniques either fail, create detectable artifacts, or only work in narrow regimes.**

That is stronger (and more novel) than “we tried extragrad and Fisher.”

To make that framing stick, the paper needs a more “benchmark/evaluation” posture:

* stronger attacks
* stronger controls (especially around matched negatives / retrain floor)
* clearer decomposition of *membership vs biology* confounds

---

## Concrete revisions that would most increase publishability

If you do only a few things, do these.

### 1) Fix the privacy metric presentation

Report both:

* AUC, and
* **attack success** = `max(AUC, 1-AUC)` or advantage `2|AUC-0.5|`

Then rewrite “over-unlearning” claims accordingly.

Also: justify your “±0.03 band” using confidence intervals, not an arbitrary constant.

### 2) Strengthen the negative-control story for matched negatives

Right now, the retrain floor ≠ 0.5 suggests residual confounding. Options:

* **Within-cluster holdout negatives**: hold out some cells from the same cluster/tissue and use them as negatives (best control, but you may need a bigger cluster/dataset).
* **Conditioned attacks**: give the attacker cluster/tissue label (or stratify evaluation by label) so membership must be detected *conditional on biology*.
* Recompute matched negatives **per evaluated model** (or justify why you don’t), since latent geometry changes.

Any of these would help reviewers trust your privacy conclusions.

### 3) Add 2–4 baseline unlearning methods that are “obvious comparators”

Even simple baselines help a lot:

* “retain-only fine-tuning” (no special forgetting)
* “gradient ascent on forget loss + retain fine-tune”
* influence-function / approximate retraining baselines (even if they fail)
* SISA-style shard retraining (if feasible)

You don’t need 10 methods—just enough that your two chosen methods don’t look arbitrary.

### 4) Expand attacks

At minimum, add:

* a simple threshold attack on recon loss / ELBO
* a black-box attack variant
* maybe a likelihood-based attack (for generative models, very relevant)

Then define success as “robust across a suite of attacks” (or report the worst-case).

### 5) Make the privacy story match the data story

Either:

* **Reframe** away from patient-level deletion and toward “subpopulation unlearning,” *or*
* Add **donor-level deletion** experiments on a dataset where donors are known.

If you want to keep the GDPR/patient hook, donor-level forgetting is the cleanest fix.

### 6) Improve utility evaluation

Keep your classifier accuracy metric, but add:

* held-out ELBO / NB log-likelihood
* latent structure metrics (silhouette / ARI vs Leiden labels)
* at least one domain-relevant downstream task (DE genes, marker recovery, etc.)

And report error bars.

### 7) Tighten the narrative + contribution bullets

Right after the introduction, add 3–4 explicit contributions, e.g.:

* evaluation protocol for MIAs in scRNA VAEs with biological matching
* empirical finding: structured vs scattered memorization
* characterization of failure modes (posterior collapse signature, etc.)
* cross-dataset evidence of brittleness


